GO:0048244 phytanoyl-CoA dioxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048244 describes phytanoyl-CoA dioxygenase activity, the peroxisomal enzyme that catalyzes the first alpha-oxidation step of phytanic acid, converting phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.
• The reaction requires 2-oxoglutarate, oxygen, iron(II), ascorbate, and additionally GTP or ATP with Mg2+ for full activity.
• Deficiency of phytanoyl-CoA hydroxylase causes Refsum disease, a peroxisomal disorder with neurologic and retinal degeneration.
• The enzyme recognizes 3-methyl-branched acyl-CoAs, and substrate specificity is linked to disease-causing mutations.
• PHYHD1, a related phytanoyl-CoA dioxygenase domain-containing protein, may act as an oxygen sensor linked to RNA and carbohydrate metabolism.
• Studying GO:0048244 requires assays for hydroxylase activity, mutation analysis, and CRISPR models to dissect gene function.
Description
Phytanoyl-CoA dioxygenase activity (GO:0048244) is a molecular function that catalyzes the hydroxylation of phytanoyl-CoA to 2-hydroxyphytanoyl-CoA, the first committed step in the alpha-oxidation of phytanic acid. This peroxisomal enzyme belongs to the 2-oxoglutarate-dependent dioxygenase family and requires iron(II), 2-oxoglutarate, oxygen, and ascorbate, with additional stimulation by GTP or ATP and Mg2+. The activity is essential for the degradation of branched-chain fatty acids derived from dietary sources, and its impairment leads to the accumulation of phytanic acid, a hallmark of Refsum disease. Researchers study GO:0048244 to understand peroxisomal fatty acid metabolism, inherited metabolic disorders, and the broader roles of 2-oxoglutarate dioxygenases in cellular signaling and oxygen sensing.
phytanoyl-CoA dioxygenase activity At A Glance
| GO ID | GO:0048244 |
|---|---|
| GO term | phytanoyl-CoA dioxygenase activity |
| Ontology | molecular_function |
| Synonym | phytanoyl-CoA 2-hydroxylase activity; phytanoyl-CoA alpha-hydroxylase activity; phytanoyl-CoA hydroxylase activity |
| Major function | Catalyzes alpha-hydroxylation of phytanoyl-CoA in peroxisomal alpha-oxidation |
| Cofactors | 2-oxoglutarate, O2, Fe(II), ascorbate; GTP or ATP and Mg2+ enhance activity |
| Substrate specificity | Recognizes 3-methyl-branched acyl-CoAs, including phytanoyl-CoA |
| Localization | Peroxisome (inferred from enzyme function and disease pathology) |
| Related disease | Refsum disease due to mutations in PHYH |
What Is GO:0048244?
Phytanoyl-CoA dioxygenase activity is defined as the catalysis of the reaction: 2-oxoglutarate + O2 + phytanoyl-CoA = 2-hydroxyphytanoyl-CoA + CO2 + succinate. In this reaction, the enzyme uses 2-oxoglutarate as a co-substrate and molecular oxygen to hydroxylate phytanoyl-CoA at the alpha carbon, producing 2-hydroxyphytanoyl-CoA, carbon dioxide, and succinate. This activity is synonymous with phytanoyl-CoA 2-hydroxylase, phytanoyl-CoA alpha-hydroxylase, and phytanoyl-CoA hydroxylase.
Why Is phytanoyl-CoA dioxygenase activity Important in Cell Biology?
GO:0048244 is critical because it initiates the only known pathway for degradation of phytanic acid, a branched-chain fatty acid that cannot be beta-oxidized. Loss of this activity causes Refsum disease, an inherited peroxisomal disorder characterized by retinitis pigmentosa, peripheral neuropathy, and cerebellar ataxia. Beyond disease, the enzyme is a model for 2-oxoglutarate-dependent dioxygenases, which are involved in oxygen sensing, epigenetic regulation, and metabolism. Understanding its mechanism and regulation provides insights into peroxisomal biology and potential therapeutic targets.
• Initiates alpha-oxidation of phytanic acid, a dietary branched-chain fatty acid.
• Deficiency causes Refsum disease, a neurologic disorder with retinal degeneration.
• Serves as a paradigm for 2-oxoglutarate/Fe(II)-dependent dioxygenases.
• Substrate specificity determines the range of 3-methyl-branched acyl-CoAs processed.
• Requires GTP or ATP and Mg2+ for optimal activity, linking energy status to fatty acid oxidation.
• Mutations in PHYH alter enzyme structure and function, providing genotype-phenotype correlations.
• Related protein PHYHD1 may act as an oxygen sensor, expanding roles beyond fatty acid metabolism.
• Enzyme activity is induced by phytanic acid, indicating adaptive regulation.
• Provides a target for diagnostic assays in peroxisomal disorders.
• Offers opportunities for CRISPR-based disease modeling and drug screening.
Molecular Mechanism of phytanoyl-CoA dioxygenase activity
Substrate recognition and binding
In simple terms: The enzyme grabs phytanoyl-CoA, a branched fat molecule, and holds it in place for modification.
Phytanoyl-CoA dioxygenase specifically binds phytanoyl-CoA and related 3-methyl-branched acyl-CoAs, as shown by substrate spectrum studies. The enzyme recognizes the CoA moiety and the branched acyl chain, ensuring selectivity for alpha-oxidation substrates. Mutations in the enzyme can alter substrate binding, leading to reduced activity and disease.
Catalytic hydroxylation
In simple terms: Using oxygen and a helper molecule, the enzyme adds a hydroxyl group to phytanoyl-CoA, converting it to 2-hydroxyphytanoyl-CoA.
The catalytic mechanism involves a 2-oxoglutarate- and Fe(II)-dependent dioxygenase reaction, where 2-oxoglutarate is decarboxylated to succinate while molecular oxygen is used to hydroxylate phytanoyl-CoA at the alpha carbon. This yields 2-hydroxyphytanoyl-CoA, CO2, and succinate. The reaction is stereospecific and requires ascorbate to maintain iron in the reduced state.
Cofactor requirements and energy dependence
In simple terms: The enzyme needs several cofactors and can be boosted by energy molecules like GTP or ATP.
In addition to 2-oxoglutarate, O2, Fe(II), and ascorbate, phytanoyl-CoA hydroxylase activity is stimulated by GTP or ATP in the presence of Mg2+. This nucleotide requirement suggests a link between cellular energy status and alpha-oxidation. The enzyme's activity can be measured in liver homogenates and is dependent on these cofactors.
Enzyme maturation and iron binding
In simple terms: The enzyme must be properly folded and bind iron to work; mutations that disrupt this cause disease.
Studies on unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase show that the enzyme undergoes processing and requires iron binding for activity. Mutation of iron-binding ligands abolishes catalytic function, and disease-causing mutations in PHYH often affect these residues or the active site. This highlights the importance of structural integrity for GO:0048244 activity.
Regulation by substrate availability
In simple terms: When more phytanic acid is present, the body makes more of this enzyme to break it down.
Phytanoyl-CoA hydroxylase activity is induced by phytanic acid, indicating a substrate-driven regulatory mechanism. This adaptive response helps prevent accumulation of phytanic acid, which is toxic at high levels. The induction may involve peroxisome proliferator-activated receptors or other metabolic sensors, though the exact pathway requires further study.
Key Genes Involved in GO:0048244 phytanoyl-CoA dioxygenase activity
The following genes and proteins are directly associated with phytanoyl-CoA dioxygenase activity (GO:0048244) or its related pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PHYH | Encodes phytanoyl-CoA 2-hydroxylase, the enzyme catalyzing GO:0048244 | Mutations cause Refsum disease; target for enzyme assays and structural studies |
| PHYHD1 | Phytanoyl-CoA dioxygenase domain-containing protein 1, putative oxygen sensor | Linked to RNA and carbohydrate metabolism; potential regulatory role |
| PEX7 | Peroxisomal targeting signal 2 receptor, required for PHYH import | Defects cause rhizomelic chondrodysplasia punctata, affecting alpha-oxidation |
| PEX5 | Peroxisomal targeting signal 1 receptor, involved in peroxisomal protein import | Mutations lead to peroxisome biogenesis disorders with phytanic acid accumulation |
| ACOX1 | Acyl-CoA oxidase 1, involved in fatty acid beta-oxidation | Indirectly affects phytanic acid metabolism; not directly GO:0048244 |
| SCP2 | Sterol carrier protein 2, involved in lipid transport | May influence substrate availability for alpha-oxidation |
| HSD17B4 | D-bifunctional protein, involved in peroxisomal fatty acid oxidation | Deficiency can alter phytanic acid levels |
| CYP4F2 | Cytochrome P450, involved in omega-oxidation of phytanic acid | Alternative pathway for phytanic acid metabolism |
| CYP4F3 | Cytochrome P450, omega-oxidation of phytanic acid | Provides backup pathway when alpha-oxidation is defective |
| ALDH3A2 | Fatty aldehyde dehydrogenase, involved in fatty acid metabolism | May affect phytanic acid derivatives |
| SLC27A2 | Fatty acid transport protein, activates very long-chain fatty acids | Influences phytanic acid uptake and activation |
| ACAA1 | Acetyl-CoA acyltransferase 1, peroxisomal thiolase | Involved in downstream beta-oxidation of branched fatty acids |
| HACL1 | 2-hydroxyacyl-CoA lyase 1, acts downstream of alpha-oxidation | Metabolizes 2-hydroxyphytanoyl-CoA produced by GO:0048244 |
| PHYHIP | Phytanoyl-CoA hydroxylase interacting protein | May regulate enzyme activity or stability |
| IDH1 | Isocitrate dehydrogenase 1, produces 2-oxoglutarate | Supplies co-substrate for dioxygenase reaction |
| GOT2 | Glutamate oxaloacetate transaminase 2, involved in amino acid metabolism | May influence 2-oxoglutarate levels |
| SLC25A1 | Mitochondrial citrate carrier, affects 2-oxoglutarate availability | Indirectly supports dioxygenase activity |
| OGDH | 2-oxoglutarate dehydrogenase, consumes 2-oxoglutarate | May compete for co-substrate |
How Is phytanoyl-CoA dioxygenase activity Regulated?
Phytanoyl-CoA dioxygenase activity is regulated at multiple levels. Enzyme activity is induced by phytanic acid, suggesting substrate-mediated upregulation. The requirement for GTP or ATP and Mg2+ indicates that cellular energy status can modulate activity. Additionally, the enzyme undergoes processing from an unprocessed to a mature form, and iron binding is essential for catalysis. Mutations in PHYH that affect folding or cofactor binding reduce activity and cause Refsum disease. The related protein PHYHD1 may act as an oxygen sensor, potentially linking dioxygenase activity to oxygen availability and metabolic signaling. However, the precise regulatory pathways, including transcriptional control and post-translational modifications, remain areas of active investigation.
phytanoyl-CoA dioxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PHYH | Refsum disease; phytanic acid accumulation | PHYH knockout cell lines (e.g., HEK293, fibroblasts) and patient-derived fibroblasts |
| PHYH | Refsum disease with missense mutations | Point-mutation knock-in models (e.g., PHYH Cys185Ser) to study enzyme stability |
| PHYHD1 | Metabolic regulation and oxygen sensing | Overexpression and knockout cell lines for RNA and carbohydrate metabolism assays |
| PEX7 | Rhizomelic chondrodysplasia punctata | PEX7 knockout models to study peroxisomal import defects |
| PEX5 | Zellweger spectrum disorder | PEX5 knockout cell lines to assess phytanoyl-CoA hydroxylase localization |
Refsum disease
Refsum disease is an autosomal recessive peroxisomal disorder caused by mutations in PHYH, leading to deficient phytanoyl-CoA hydroxylase activity (GO:0048244). Patients accumulate phytanic acid in plasma and tissues, resulting in retinitis pigmentosa, peripheral neuropathy, cerebellar ataxia, and anosmia. Enzyme activity measurements in patient liver samples confirm the deficiency. Structure-function studies of PHYH mutations provide insights into genotype-phenotype correlations and potential therapeutic targets.
Peroxisomal biogenesis disorders
Disorders of peroxisome biogenesis, such as Zellweger spectrum disorders, can indirectly affect phytanoyl-CoA dioxygenase activity because the enzyme is peroxisomal and requires proper import machinery. Defects in PEX genes lead to mislocalization or loss of the enzyme, contributing to phytanic acid accumulation and neurologic symptoms. Measuring phytanoyl-CoA hydroxylase activity in liver biopsies can help diagnose these conditions.
PHYHD1 and metabolic regulation
PHYHD1, a phytanoyl-CoA dioxygenase domain-containing protein, has been proposed as a putative oxygen sensor associated with RNA and carbohydrate metabolism. While its exact enzymatic activity may differ from GO:0048244, it shares sequence similarity and may regulate metabolic pathways. Dysregulation of PHYHD1 could contribute to metabolic disorders, though further research is needed to establish links to human disease.
From phytanoyl-CoA dioxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PHYH abolish phytanoyl-CoA dioxygenase activity? | PHYH knockout cell line (e.g., HepG2 or HEK293) |
| How do disease-causing mutations affect enzyme function? | Point-mutation knock-in of PHYH mutations (e.g., C185S) |
| Can wild-type PHYH rescue phytanic acid accumulation? | Knock-in of tagged PHYH (e.g., FLAG-PHYH) for expression and localization |
| Does PHYHD1 act as an oxygen sensor? | Overexpression of PHYHD1 in cell lines under hypoxia |
| What is the substrate specificity of phytanoyl-CoA hydroxylase? | In vitro enzyme assays with purified recombinant PHYH and various acyl-CoAs |
| How is phytanoyl-CoA hydroxylase regulated by phytanic acid? | Inducible overexpression of PHYH in cells treated with phytanic acid |
How to Study the phytanoyl-CoA dioxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Conversion of phytanoyl-CoA to 2-hydroxyphytanoyl-CoA | Diagnosis of Refsum disease and enzyme kinetics |
| Site-directed mutagenesis | Effect of specific mutations on enzyme function | Structure-function analysis of PHYH |
| CRISPR knockout | Loss of PHYH expression and activity | Modeling Refsum disease and identifying compensatory pathways |
| CRISPR knock-in | Expression of mutant or tagged PHYH | Studying disease mutations and protein localization |
| RNA-seq | Global transcriptional changes | Identifying pathways regulated by phytanoyl-CoA dioxygenase |
| Proteomics | Protein abundance and interactions | Discovering PHYH binding partners and post-translational modifications |
| Lipidomics | Phytanic acid and 2-hydroxyphytanoyl-CoA levels | Assessing enzyme activity in cells and tissues |
| Immunofluorescence | Subcellular localization of PHYH | Confirming peroxisomal targeting |
Enzyme activity assays
Phytanoyl-CoA dioxygenase activity can be measured using radiolabeled or fluorescently labeled phytanoyl-CoA substrates, with product formation detected by HPLC or mass spectrometry. These assays require cofactors such as 2-oxoglutarate, Fe(II), ascorbate, and GTP or ATP with Mg2+. Activity is typically assessed in liver homogenates or purified enzyme preparations.
Mutational analysis and structure-function studies
Site-directed mutagenesis of PHYH, followed by expression in cell lines and activity assays, helps identify residues critical for catalysis or substrate binding. Structural modeling and iron-binding studies provide insights into how mutations cause Refsum disease. These methods are essential for understanding the molecular basis of GO:0048244.
CRISPR-based knockout and knock-in models
CRISPR/Cas9 can generate PHYH knockout cell lines to study loss of function, or knock-in specific patient mutations to model Refsum disease. These models enable downstream analyses such as lipid profiling, RNA sequencing, and proteomics to uncover pathways affected by phytanoyl-CoA dioxygenase deficiency.
Omics and metabolic profiling
RNA-seq and proteomics can reveal global changes in gene expression and protein abundance upon modulation of phytanoyl-CoA dioxygenase activity. Metabolomics, particularly lipidomics, quantifies phytanic acid and 2-hydroxyphytanoyl-CoA levels, providing direct readouts of enzyme function. These approaches help link GO:0048244 to broader metabolic networks.
How CRISPR Can Be Used to Study GO:0048244 phytanoyl-CoA dioxygenase activity
Knockout
CRISPR/Cas9-mediated knockout of PHYH creates cell lines completely lacking phytanoyl-CoA dioxygenase activity, ideal for studying loss-of-function phenotypes such as phytanic acid accumulation and altered lipid metabolism. These models can be used to test rescue by wild-type or mutant PHYH and to identify downstream effects.
Point Mutation
Introducing specific patient mutations (e.g., PHYH C185S) via CRISPR knock-in allows precise modeling of Refsum disease alleles. These point-mutation models help dissect how individual amino acid changes affect enzyme stability, cofactor binding, and catalytic activity.
Knock-in
Knock-in of tagged PHYH (e.g., FLAG or GFP) enables visualization and purification of the enzyme for interaction studies. This approach also allows controlled expression of wild-type or mutant PHYH under endogenous regulatory elements, providing physiological relevance.
Overexpression
CRISPR activation or lentiviral overexpression of PHYH or PHYHD1 can be used to study gain-of-function effects, such as enhanced phytanic acid oxidation or oxygen sensing. Overexpression models are useful for identifying dose-dependent phenotypes and for screening small-molecule modulators.
How EDITGENE Supports phytanoyl-CoA dioxygenase activity Research
Researchers studying phytanoyl-CoA dioxygenase activity-related genes often need to determine whether a candidate gene is causally involved in enzyme function, substrate specificity, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous investigation of GO:0048244 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for phytanoyl-CoA dioxygenase activity research.
Frequently Asked Questions About phytanoyl-CoA dioxygenase activity
What is phytanoyl-CoA dioxygenase activity?
Phytanoyl-CoA dioxygenase activity (GO:0048244) is the enzyme activity that catalyzes the alpha-hydroxylation of phytanoyl-CoA to 2-hydroxyphytanoyl-CoA, the first step in phytanic acid breakdown.
What genes are involved in phytanoyl-CoA dioxygenase activity?
The primary gene is PHYH, which encodes phytanoyl-CoA 2-hydroxylase. Related genes include PHYHD1, PEX7, and PEX5, which affect peroxisomal import and function.
What disease is caused by deficiency of phytanoyl-CoA dioxygenase activity?
Deficiency causes Refsum disease, a peroxisomal disorder characterized by retinitis pigmentosa, peripheral neuropathy, and cerebellar ataxia.
What cofactors are required for phytanoyl-CoA dioxygenase activity?
The enzyme requires 2-oxoglutarate, oxygen, iron(II), and ascorbate, and is stimulated by GTP or ATP with Mg2+.
How is phytanoyl-CoA dioxygenase activity measured?
It is measured using enzyme assays with phytanoyl-CoA as substrate, often in liver homogenates or purified enzyme preparations, detecting product formation by HPLC or mass spectrometry.
What is the role of PHYH mutations in Refsum disease?
Mutations in PHYH reduce or abolish enzyme activity, leading to phytanic acid accumulation and disease symptoms. Structure-function studies reveal how specific mutations affect catalysis.
Is phytanoyl-CoA dioxygenase activity regulated by substrate?
Yes, enzyme activity is induced by phytanic acid, suggesting a substrate-driven regulatory mechanism.
What is PHYHD1 and how is it related to phytanoyl-CoA dioxygenase?
PHYHD1 is a phytanoyl-CoA dioxygenase domain-containing protein that may act as an oxygen sensor and is associated with RNA and carbohydrate metabolism.
Can CRISPR be used to study phytanoyl-CoA dioxygenase activity?
Yes, CRISPR knockout, knock-in, and point-mutation models of PHYH and related genes are powerful tools to study enzyme function and disease mechanisms.
What are the research methods for studying GO:0048244?
Common methods include enzyme activity assays, mutational analysis, CRISPR models, RNA-seq, proteomics, and lipidomics to assess phytanic acid levels.
Conclusion
Phytanoyl-CoA dioxygenase activity (GO:0048244) is a critical peroxisomal enzyme function responsible for initiating phytanic acid alpha-oxidation. Its deficiency causes Refsum disease, and its mechanism involves 2-oxoglutarate-dependent hydroxylation with iron and ascorbate cofactors. Understanding this activity provides insights into peroxisomal disorders, lipid metabolism, and the broader family of dioxygenases. CRISPR-based models and advanced omics technologies are essential for dissecting its regulation and identifying therapeutic targets.
References
- 1. Zomer AW et al.. 2000. Phytanoyl-CoA hydroxylase activity is induced by phytanic acid.. Eur J Biochem 267(13):4063-7 PMID: 10866807
- 2. Ala-Nisula T et al.. 2023. Human phytanoyl-CoA dioxygenase domain-containing 1 (PHYHD1) is a putative oxygen sensor associated with RNA and carbohydrate metabolism.. FEBS Lett 597(12):1651-1666 PMID: 37235702
- 3. Croes K et al.. 2000. Phytanoyl-CoA hydroxylase: recognition of 3-methyl-branched acyl-coAs and requirement for GTP or ATP and Mg(2+) in addition to its known hydroxylation cofactors.. J Lipid Res 41(4):629-36 PMID: 10744784
- 4. Kershaw NJ et al.. 2001. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A.. Bioorg Med Chem Lett 11(18):2545-8 PMID: 11549466
- 5. Mukherji M et al.. 2001. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.. Hum Mol Genet 10(18):1971-82 PMID: 11555634
- 6. Foulon V et al.. 2003. Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?. J Lipid Res 44(12):2349-55 PMID: 12923223
- 7. Jansen GA et al.. 1998. Characterization of phytanoyl-Coenzyme A hydroxylase in human liver and activity measurements in patients with peroxisomal disorders.. Clin Chim Acta 271(2):203-11 PMID: 9565335
- 8. Searls T et al.. 2005. Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands.. J Lipid Res 46(8):1660-7 PMID: 15930519
